Estradiol production by granulosa cells of normal and polycystic ovaries: relationship to menstrual cycle history and concentrations of gonadotropins and sex steroids in follicular fluid.
The underlying cause of anovulation in polycystic ovary syndrome is unknown. Circulating levels of immuno- and bioactive FSH are within the normal range, and the follicles contain measurable levels of bioactive FSH. The aim of this study was to compare estradiol (E2) production in response to FSH by granulosa cells from normal ovaries with those from polycystic ovaries derived from both anovulatory (anovPCO) and ovulatory subjects (ovPCO). Intrafollicular levels of immunoactive FSH, E2, and androstenedione in follicles of less than 12 mm were also measured. Follicular fluid steroid concentrations were obtained from 41 pairs of normal ovaries and 23 pairs of polycystic ovaries (8 anovPCO and 15 ovPCO). In size-matched follicles from each group there were no significant differences in follicular fluid FSH or E2 concentrations, but androstenedione levels were significantly higher in 5- to 11-mm follicles from ovPCO than in corresponding follicles from normal ovaries. Dose responses to FSH were determined in granulosa cells derived from 9 pairs of normal ovaries, 7 anovPCO, and 8 ovPCO. Cells from anovPCO produced 6- to 10-fold more E2 in response to FSH than normal cells, although there was no significant difference in the ED50 values. The response in cells from ovPCO was reduced compared to normal, but this difference did not reach significance. In summary, as judged by their FSH and E2 contents, polycystic ovaries do not have a higher proportion of atretic follicles than normal. Indeed, cells from anovPCO are hyperesponsive to FSH in vitro. This could be explained by stimulation of aromatase in vivo by either paracrine or, more probably, by endocrine factors, of which insulin is an arguable candidate.
Department of Obstetrics and Gynecology, St. Mary's Hospital Medical School, Imperial College of Science, Technology, and Medicine, London, United Kingdom.
H D
HD
Mason
D S
DS
Willis
R W
RW
Beard
R M
RM
Winston
R
R
Margara
S
S
Franks
D000328:Adult; D000735:Androstenedione / Q000032:analysis / Q000378:metabolism; D002478:Cells, Cultured; D004958:Estradiol / Q000378:metabolism*; D005260:Female; D005640:Follicle Stimulating Hormone / Q000032:analysis* / Q000097:blood; D015571:Follicular Fluid / Q000737:chemistry*; D006062:Gonadotropins / Q000032:analysis* / Q000378:metabolism; D006107:Granulosa Cells / Q000166:cytology / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D008597:Menstrual Cycle / Q000378:metabolism / Q000502:physiology*; D010060:Ovulation / Q000502:physiology; D011085:Polycystic Ovary Syndrome / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D011863:Radioimmunoassay
D006062:Gonadotropins; D000735:Androstenedione; D004958:Estradiol; D005640:Follicle Stimulating Hormone